The DTC microbiome testing industry needs more regulation.

Autor: Hoffmann DE; University of Maryland School of Law, Baltimore, MD, USA., von Rosenvinge EC; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA., Roghmann MC; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA., Palumbo FB; University of Maryland School of Pharmacy, Baltimore, MD, USA.; Baker & Hostetler, Washington, DC, USA., McDonald D; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, USA., Ravel J; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Jazyk: angličtina
Zdroj: Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1176-1179. Date of Electronic Publication: 2024 Mar 14.
DOI: 10.1126/science.adk4271
Abstrakt: Tests lack analytical and clinical validity, requiring more federal oversight to prevent consumer harm.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje